Cargando…
Vulvovaginal pyoderma gangrenosum in association with rituximab
Autores principales: | Maloney, Catherine, Blickenstaff, Nicholas, Kugasia, Aman, Buford, Laura Beth, Hoffman, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176040/ https://www.ncbi.nlm.nih.gov/pubmed/30302361 http://dx.doi.org/10.1016/j.jdcr.2018.09.001 |
Ejemplares similares
-
Vulvovaginal pyoderma gangrenosum associated with rituximab use in 2 patients with rheumatoid arthritis
por: Sotzen, Jason R., et al.
Publicado: (2021) -
Pyoderma gangrenosum controlled with rituximab
por: DaCunha, Matthew, et al.
Publicado: (2019) -
A case of rituximab-induced pyoderma gangrenosum
por: Georgakopoulos, Jorge R., et al.
Publicado: (2018) -
Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
por: Klumpp, Annika, et al.
Publicado: (2022) -
Penile pyoderma gangrenosum
por: Philip, Mariam, et al.
Publicado: (2013)